AKT1 and cardiac hypertrophy: This suppression results in enhanced phosphorylation of phosphatidylinositol (3,4,5)‐trisphosphate (PIP3), Akt and GSK3β [16], ultimately leading to inactivation of GSK3β and accelerating the development of cardiac hypertrophy.